View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
 PRESS RELEASE

Medidata Accelerates Business Transformation with Lisa Moneymaker as C...

Medidata Accelerates Business Transformation with Lisa Moneymaker as Chief Strategy Officer Lisa Moneymaker will lead the Strategy organization, reinforcing Medidata's commitment to long-term growth in a rapidly evolving market NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- , a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced a significant investment in its business transformation, positioning as the organization's new chief strategy officer. Lisa will now lead the company's Strategy team to advance product innovation,...

Pierre FerraguÊ
  • Pierre FerraguÊ

AMD GPUs, Cyber HW refresh, Arista, Auto cycle and more.

As always, during earnings season, we wrap-up what happened in the previous week. For our main takes summarized on a single slide, and a few words on each of the 34 names we followed last week, follow the link below.

 PRESS RELEASE

Coloplast A/S - 9M 2024/25 Earnings Release - Invitation to conference...

Coloplast A/S - 9M 2024/25 Earnings Release - Invitation to conference call on 19 August 2025 at 11.00am CEST Tuesday, 19 August 2025 at 11.00 - 12.00h CESTIn connection with the publication of Coloplast’s interim financial results for 9M 2024/25, to be released same day in the morning around 07.30h CEST, Coloplast will host a conference call to present the financial results and answer questions from investors and financial analysts. A presentation will be available on Coloplast’s website approximately 1 hour before the conference call.The webcast of the conference call will be available d...

Arnaud Autier ... (+2)
  • Arnaud Autier
  • Pierre Tegner
Arnaud Autier ... (+2)
  • Arnaud Autier
  • Pierre Tegner

Vodafone Group: 1 director

A director at Vodafone Group maiden bought 138,055 shares at 83p and the significance rating of the trade was 63/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...

Mihaly Gajda
  • Mihaly Gajda

OMV resilient despite macro strain, Petrochemicals remain weak

OMV reported clean CCS EBIT of EUR 1,031 mn in Q2 2025, down 11% QoQ and 16% YoY, broadly in line with the market consensus of EUR 1,022 mn. CCS net income came in at EUR 385 mn, also close to consensus. The differences between actual results and consensus were minimal, both at the aggregate and segment levels.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch